Feedback on IASLC Molecular Testing Guideline for Selection of Lung Cancer Patients – Revision 2016 Draft Recommendations

In August 2016, a team of experts from Diaceutics submitted a response to the IASLC Molecular Testing Guideline for Selection of Lung Cancer Patients, during the public open comment period. Here they share a summary of their thoughts and concerns.
Existing Users Log In